Graphite Bio

$8.77 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Graphite Bio

Graphite Bio, Inc. operates as a biotech company. The Company focuses on development of potentially curative therapies for patients suffering from serious diseases. Graphite Bio serves customers worldwide.

Stock Analysis

last close $9.56
1-mo return -24.4%
3-mo return -50.2%
avg daily vol. 180.5T
52-week high 34
52-week low 8.11
market cap. $555M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $--
inst own. 86.8%

Subscribe now for daily local and international financial news